How can we reduce complications associated with thrombolysis for prosthetic valve thrombosis? Reply

Basit Öğe Kaydı
dc.contributor.authorTanyeli, Omer
dc.date.accessioned2024-02-23T14:45:59Z
dc.date.available2024-02-23T14:45:59Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.endpage681en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue8en_US
dc.identifier.pmid26528519en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage680en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17731
dc.identifier.volume15en_US
dc.identifier.wosWOS:000360292000025en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Soc Cardiologyen_US
dc.relation.ispartofAnatolian Journal Of Cardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleHow can we reduce complications associated with thrombolysis for prosthetic valve thrombosis? Replyen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu